Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.
Zhu D, Li X, Ma J, Zeng J, Gan S, Dong X, Yang J, Lin X, Cai H, Song W, Li X, Zhang K, Zhang Q, Lu Y, Bu R, Shao H, Wang G, Yuan G, Ran X, Liao L, Zhao W, Li P, Sun L, Shi L, Jiang Z, Xue Y, Jiang H, Li Q, Li Z, Fu M, Liang Z, Guo L, Liu M, Xu C, Li W, Yu X, Qin G, Yang Z, Su B, Zeng L, Geng H, Shi Y, Zhao Y, Zhang Y, Yang W, Chen L. Zhu D, et al. Among authors: su b. Nat Med. 2022 May;28(5):965-973. doi: 10.1038/s41591-022-01802-6. Epub 2022 May 12. Nat Med. 2022. PMID: 35551294 Clinical Trial.
[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study].
Pan CY, Ji LN, Lu JM, Yang WY, Zhou ZG, Zou DJ, Ji QH, Han P, Liu J, Li Q, Su BL, Li YB, Gao ZN, Wang PH, Yin SN, Dong YH, Yang T, Sun K, Li H, Hong X, Lin J, Shi JM, Yang XJ, Fang H, Yan XD; SOLVETM Chinese study group. Pan CY, et al. Zhonghua Nei Ke Za Zhi. 2012 Dec;51(12):957-61. Zhonghua Nei Ke Za Zhi. 2012. PMID: 23327957 Chinese.
[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study].
Pan CY, Ji LN, Lu JM, Yang WY, Zhou ZG, Zou DJ, Ji QH, Han P, Liu J, Li Q, Su BL, Li YB, Gao ZN, Wang PH, Yin SN, Dong YH, Yang T, Sun K, Li H, Hong X, Lin J, Shi JM, Yang XJ, Fang H, Yan XD; SOLVE™ Chinese study group. Pan CY, et al. Zhonghua Nei Ke Za Zhi. 2013 Jan;52(1):11-5. Zhonghua Nei Ke Za Zhi. 2013. PMID: 23710808 Chinese.
Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia).
Yu Pan C, Han P, Liu X, Yan S, Feng P, Zhou Z, Lv X, Tian H, Jin Kui Y, Su B, Shang S, Niemoeller E. Yu Pan C, et al. Among authors: su b. Diabetes Metab Res Rev. 2014 Nov;30(8):726-35. doi: 10.1002/dmrr.2541. Diabetes Metab Res Rev. 2014. PMID: 24639432 Clinical Trial.
Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study.
Zhou X, Ji L, Ran X, Su B, Ji Q, Pan C, Weng J, Ma C, Hao C, Zhang D, Hu D; CCMR Advisory Board; CCMR-3B Study Investigators. Zhou X, et al. Among authors: su b. PLoS One. 2016 Jan 4;11(1):e0144179. doi: 10.1371/journal.pone.0144179. eCollection 2016. PLoS One. 2016. PMID: 26726883 Free PMC article.
3,434 results